PDF Print-Friendly PDF

Lee, Andrew K., M.D., M.P.H.

Medical Director

Provider Type:
  • Physician
Specialties:
  • Proton Therapy
  • Radiation Oncology for Adults

Background / Education

  • Residency in Radiation Oncology
    Harvard Medical School-Joint Center for Radiation Therapy, Boston, MA
  • Internship in Internal Medicine
    Good Samaritan Regional Medical Center, Phoenix, AZ
  • Medical Doctorate
    University of Minnesota, Minneapolis, MN
  • Master of Public Health
    Harvard School of Public Health, Boston, MA

Memberships / Honors / Awards

  • U.S. News & World Report‘s List of Best Doctors
  • University Cancer Foundation Faculty Achievement Award in Patient Care, 2014, The University of Texas MD Anderson Cancer Center
  • American Society of Clinical Oncology
  • American Urological Association
  • American Society for Radiation Oncology

Publications

  • Towards effective and efficient patient-specific quality assurance for spot-scanning proton therapy

    Cancers, 2015

  • Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer

    Physics in Medicine and Biology, 2014

  • Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial

    International Journal of Radiation Oncology, 2014

  • The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer

    American Journal of Clinical Oncology, 2014

  • Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States

    Journal of Urology, 2014

Show all Publications
  • Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic

    Journal of the National Comprehensive Cancer Network, 2014

  • A single-field integrated boost treatment planning technique for spot scanning proton therapy

    Radiation Oncology, 2014

  • Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance

    Medical Physics, 2013

  • Establishing and expanding the indications for proton and particle therapy

    Acta Oncologica, 2013

  • Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors

    Medical Dosimetry, 2013

  • A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy

    International Journal of Radiation Oncology, 2013

  • Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients

    Prostate Cancer and Prostatic Diseases, 2013

  • Statistical Assessment of Proton Treatment Plans under Setup and Range Uncertainties

    International Journal of Radiation Oncology, 2013

  • Declining use of brachytherapy for the treatment of prostate cancer

    Brachytherapy, 2013

  • Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer

    Practical Radiation Oncology, 2013

  • Core Physics Competencies for Proton Therapy Training of Radiation Oncology and Medical Physics Residents and Fellows

    International Journal of Radiation Oncology, 2013

  • Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer

    International Journal of Radiation Oncology, 2013

  • Dosimetric Effects of Weight Loss or Gain During Volumetric-Modulated Arc Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer

    Medical Dosimetry, 2013

  • Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?

    International Journal of Radiation Oncology , 2012

  • Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?

    European Journal of Cancer, 2012

  • Screening Colonoscopy Before Prostate Cancer Treatment Can Detect Colorectal Cancers in Asymptomatic Patients and Reduce the Rate of Complications After Brachytherapy

    Practical Radiation Oncology, 2012

  • Uncertainty incorporated beam angle optimization for IMPT treatment planning

    Medical Physics, 2012

  • Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer

    Annals of Oncology, 2012

  • Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy

    Journal of Applied Clinical Medical Physics, 2012

  • In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors

    Radiation Measurements, 2012

  • Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer

    Physics in Medicine and Biology, 2012

  • PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era

    International Journal of Radiation Oncology, 2012

  • Verification of proton range, position, and intensity in IMPT with a 3D liquid scintillator detector system

    Medical Physics, 2012

  • Proton beam therapy for the treatment of prostate cancer

    Practical Radiation Oncology, 2012

  • A Comprehensive Comparison of IMRT and VMAT Plan Quality for Prostate Cancer Treatment

    International Journal of Radiation Oncology, 2012

  • Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy

    Brachytherapy, 2012

  • Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy

    Physica Medica, 2011

  • Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches

    Journal of Applied Clinical Medical Physics, 2011

  • Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease? 

    International Journal of Radiation Oncology, 2011

  • Patient-Specific Quality Assurance for Prostate Cancer Patients Receiving Spot Scanning Proton Therapy Using Single-Field Uniform Dose

    International Journal of Radiation Oncology, 2011

  • Role of radiation therapy for the treatment of lymph nodes in urologic malignancies

    Urologic Clinics of North America, 2011

  • Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer

    Journal of Drug, Healthcare and Patient Safety, 2011

  • A Beam-specific Planning Target Volume (PTV) Design for Proton Therapy to Account for Setup and Range Uncertainties

    International Journal of Radiation Oncology, 2011

  • A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy

    American Journal of Clinical Oncology, 2010

  • Toward a real-time in vivo dosimetry system using plastic scintillation detectors

    International Journal of Radiation Oncology, 2010

  • Spot Scanning Proton Beam Therapy for Prostate Cancer: Treatment Planning Technique and Analysis of Consequences of Rotational and Translational Alignment Errors

    International Journal of Radiation Oncology, 2010

  • Late Rectal Toxicity on RTOG 94-06: Analysis Using a Mixture Lyman Model

    International Journal of Radiation Oncology, 2010

  • Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer

    Physics in Medicine and Biology, 2010

  • Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy

    Journal of Urology, 2009

  • Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer

    International Journal of Radiation Oncology, 2009

  • The MD Anderson Proton Therapy System

    Medical Physics, 2009

  • Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience

    Urology, 2009

  • Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans

    International Journal of Radiation Oncology, 2008

  • Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?

    Urologic Oncology, 2008

  • Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer

    International Journal of Radiation Oncology, 2008

  • Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer

    Physics in Medicine and Biology, 2008

  • Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time

    Journal of Urology, 2008

  • Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer

    International Journal of Radiation Oncology, 2007

  • Commentary on "Cancer Specific Mortality After Radiation Therapy with Short-Course Hormonal Therapy or Radical Prostatectomy in Men with Localized, Intermediate-Risk to High-Risk Prostate Cancer"

    The American Journal of Hematology/Oncology, 2007

  • Implication of CT table sag on geometrical accuracy during virtual simulation

    Medical Dosimetry, 2007

  • Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer

    International Journal of Radiation Oncology, 2007

  • Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?

    Radiotherapy & Oncology, 2007

  • Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate

    Physics in Medicine and Biology, 2007

  • Using prostate-specific antigen doubling time in clinical practice

    BJU International, 2007

  • Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment

    International Journal of Radiation Oncology , 2007

  • Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?

    BJU International, 2007

  • Reducing metal artifacts in cone-beam CT images by preprocessing projection data

    International Journal of Radiation Oncology, 2006

  • Late gastrointestinal toxicity after radiation for prostate cancer

    Cancer, 2006

  • Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

    Cancer, 2006

  • Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer

    Cancer, 2006

  • Update on radiation therapy in prostate cancer

    Hematology/Oncology Clinics of North America, 2006

  • Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy

    International Journal of Radiation Oncology , 2006

  • Radiation therapy combined with hormone therapy for prostate cancer

    Seminars in Radiation Oncology, 2006

  • Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy

    International Journal of Radiation Oncology, 2005

  • Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy

    International Journal of Radiation Oncology, 2005

  • Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy

    International Journal of Radiation Oncology, 2005

  • Symptomatic local recurrence of prostate carcinoma after radiation therapy

    Cancer, 2005

  • Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?

    Urology, 2005

  • Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy

    International Journal of Radiation Oncology, 2005

  • Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy

    International Journal of Radiation Oncology, 2005

  • Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy

    Journal of Clinical Oncology, 2005

  • Comparison of treatment volumes and techniques in prostate cancer radiation therapy

    American Journal of Clinical Oncology, 2005

  • Mortality after cure of testicular seminoma

    Journal of Clinical Oncology, 2004

  • In vivo tumor imaging in mice with near-infrared labeled endostatin

    Molecular Cancer Therapeutics, 2004

  • Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study

    International Journal of Radiation Oncology, 2004

  • Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure

    Urology, 2004

  • Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer

    Journal of the National Medical Association, 2004

  • Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?

    Urologic Oncology, 2003

  • Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma

    International Journal of Radiation Oncology, 2003

  • Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate

    Journal of Urology, 2003

  • Current results of brachytherapy for soft tissue sarcoma

    Current Opinion in Oncology, 2003

  • Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer

    International Journal of Radiation Oncology, 2003

  • Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer

    International Journal of Radiation Oncology, 2003

  • Uncertainties in physical and biological targeting with radiation therapy

    Rays, 2003

  • Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer

    Journal of Urology, 2002

  • Optimizing patient selection for prostate monotherapy

    International Journal of Radiation Oncology, 2001

  • Stereotactic radiosurgery for patients with single brain metastasis

    Journal of Radiosurgery, 1998

  • Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver

    Cell Biology and Toxicology, 1997

Texas Center for Proton Therapy is ready to help you fight cancer with one of the nation’s most advanced cancer-fighting technologies.

Request an Appointment